Vaccines 2020: Big Pharma’s Admissions of Fraud By James Grundvig

Under the cover of the 2019 holidays, Big Pharma planted a couple of initiatives to drive vaccine uptake and compliance through the roof well into the next decade. Beyond the mandates passed in California and New York, and then the blowback in New Jersey—the failed attempt to ban religious exemptions—combined with the hysteria over the measles outbreak in Samoa at the end of last year, it seemed Big Pharma and its proxies owned the momentum heading into 2020.

Then something strange happened.

In the first week of December, the WHO hosted the Global Vaccine Safety Summit in Geneva, Switzerland. Instead of “business as usual,” the two-day conference fell into an unusual intellectual gridlock. Doubt seeped into the pro-vaccine “choir” of doctors and scientists.

Read More